Gestational diabetes and screening during pregnancy

Area of Science:

• Endocrinology
• Perinatal Medicine
• Maternal-Fetal Medicine

Background:

• Gestational diabetes can lead to diabetogenic fetopathy, a condition characterized by elevated fetal insulin.
• The oral glucose tolerance test (OGTT) has limitations in accurately screening for this condition.
• Fetal insulin is excreted in urine and contributes to amniotic fluid insulin levels.

Purpose of the Study:

• To evaluate the reliability of amniotic fluid insulin content for diagnosing diabetogenic fetopathy.
• To compare the diagnostic accuracy of amniotic fluid insulin with the OGTT in high-risk pregnancies.

Main Methods:

• Analysis of amniotic fluid insulin levels in pregnant women with potential diabetes.
• Correlation of amniotic fluid insulin levels with fetal outcomes and OGTT results.
• Measurement of umbilical cord blood and fetal urine insulin levels.

Main Results:

• Amniotic fluid insulin content effectively distinguished between fetuses with and without diabetogenic fetopathy.
• Mean amniotic fluid insulin levels were approximately seven times higher in cases of diabetogenic fetopathy.
• The OGTT showed variable blood sugar responses, with some patients having normal or moderately elevated levels despite the presence of fetopathy.

Conclusions:

• Amniotic fluid insulin measurement is a more reliable diagnostic tool for diabetogenic fetopathy than the OGTT.
• Elevated amniotic fluid insulin levels indicate fetal hyperinsulinism associated with gestational diabetes.
• This diagnostic approach aids in identifying fetuses at risk for complications of maternal diabetes.